Free Trial

Oxford Nanopore Technologies (ONT) Competitors

Oxford Nanopore Technologies logo
GBX 147.47 +5.47 (+3.85%)
As of 07/3/2025 12:25 PM Eastern

ONT vs. BTG, ABC, GNS, ERGO, SLN, PRTC, OXB, HZD, FARN, and VRP

Should you be buying Oxford Nanopore Technologies stock or one of its competitors? The main competitors of Oxford Nanopore Technologies include BTG (BTG), Abcam (ABC), Genus (GNS), Ergomed (ERGO), Silence Therapeutics (SLN), PureTech Health (PRTC), Oxford Biomedica (OXB), Horizon Discovery Group plc (HZD.L) (HZD), Faron Pharmaceuticals Oy (FARN), and Verona Pharma plc (VRP.L) (VRP). These companies are all part of the "biotechnology" industry.

Oxford Nanopore Technologies vs. Its Competitors

Oxford Nanopore Technologies (LON:ONT) and BTG (LON:BTG) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, media sentiment, earnings and profitability.

Oxford Nanopore Technologies currently has a consensus price target of GBX 220, suggesting a potential upside of 49.19%. Given Oxford Nanopore Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe Oxford Nanopore Technologies is more favorable than BTG.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Oxford Nanopore Technologies
0 Sell rating(s)
0 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
3.00
BTG
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, BTG had 8 more articles in the media than Oxford Nanopore Technologies. MarketBeat recorded 10 mentions for BTG and 2 mentions for Oxford Nanopore Technologies. Oxford Nanopore Technologies' average media sentiment score of 0.37 beat BTG's score of 0.22 indicating that Oxford Nanopore Technologies is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Oxford Nanopore Technologies
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BTG
1 Very Positive mention(s)
2 Positive mention(s)
7 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

38.4% of Oxford Nanopore Technologies shares are held by institutional investors. 32.6% of Oxford Nanopore Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

BTG has a net margin of 0.00% compared to Oxford Nanopore Technologies' net margin of -94.82%. BTG's return on equity of 0.00% beat Oxford Nanopore Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Oxford Nanopore Technologies-94.82% -26.02% -14.42%
BTG N/A N/A N/A

BTG has higher revenue and earnings than Oxford Nanopore Technologies. Oxford Nanopore Technologies is trading at a lower price-to-earnings ratio than BTG, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Oxford Nanopore Technologies£184.78M7.57-£175.21M-£18.58-7.94
BTG£914.10M0.00N/A£28.50N/A

Summary

BTG beats Oxford Nanopore Technologies on 7 of the 13 factors compared between the two stocks.

Get Oxford Nanopore Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for ONT and its competitors with MarketBeat's FREE daily newsletter.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ONT vs. The Competition

MetricOxford Nanopore TechnologiesBiotechnology IndustryMedical SectorLON Exchange
Market Cap£1.40B£128.03M£5.49B£2.97B
Dividend YieldN/A3.74%5.38%5.02%
P/E Ratio-7.943.4227.47146.59
Price / Sales7.574,132.26408.86240,167.57
Price / Cash4.0413.1936.6327.97
Price / Book2.2043.388.095.32
Net Income-£175.21M-£92.79M£3.17B£5.90B
7 Day Performance8.63%2.64%2.81%0.90%
1 Month Performance22.06%2.50%3.67%5.18%
1 Year Performance40.98%178.35%35.41%80.75%

Oxford Nanopore Technologies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ONT
Oxford Nanopore Technologies
2.2437 of 5 stars
GBX 147.47
+3.9%
GBX 220
+49.2%
+44.0%£1.40B£184.78M-7.941,281
BTG
BTG
N/AN/AN/AN/A£3.26B£914.10M29.474,690
ABC
Abcam
N/AN/AN/AN/A£2.81B£350.40M20,433.331,650Gap Up
High Trading Volume
GNS
Genus
0.7148 of 5 stars
GBX 2,004.97
-2.0%
GBX 2,150
+7.2%
+25.7%£1.31B£666.67M166.19480News Coverage
Gap Up
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
PRTC
PureTech Health
2.3588 of 5 stars
GBX 125.40
+0.6%
GBX 455
+262.8%
-27.7%£376.68M£521.32K-5.14300
OXB
Oxford Biomedica
2.3554 of 5 stars
GBX 314.60
-0.6%
GBX 380
+20.8%
+4.9%£334.43M£98.31M-2.34891Gap Up
HZD
Horizon Discovery Group plc (HZD.L)
N/AN/AN/AN/A£302.98M£54.63M-33.55416
FARN
Faron Pharmaceuticals Oy
N/AGBX 209
+3.2%
N/A+129.7%£280.59MN/A-5.5934Gap Up
VRP
Verona Pharma plc (VRP.L)
N/AN/AN/AN/A£228MN/A-1.6822Positive News
Gap Up

Related Companies and Tools


This page (LON:ONT) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners